跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Emzol 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Emzol 40
Approved
STANDARD
Emzol 40
Gufic Stridden Biopharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c0e00b2a234b12d4
Company
Gufic Stridden Biopharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c0e00b2a234b12d4
Drug Approval Philippines Name
Emzol 40
Product Name
Emzol 40
Registration Number
DRP-5882-01
Brand Name
Emzol 40
Generic Name
Omeprazole (as Sodium)
Dosage Form
Lyophilized Powder For Iv Injection/Infusion
Dosage Strength
40 mg
Manufacturer
Gufic Stridden Biopharma Pvt. Ltd.
Importer
SUHITAS PHARMACEUTICALS INC.
Distributor
Ellebasy Medicale Trading
Issuance Date
28 September 2022
Expiry Date
09 December 2027
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c0e00b2a234b12d4
Type
Standard
Back to Philippines FDA Approvals